Stammdaten
Vyome Holdings Inc., a clinical-stage healthcare company, develops therapeutic products targeting immuno-inflammatory and rare diseases in the United States and global markets. The company was founded in 2017 and is based in Princeton, New Jersey.
Unternehmen & Branche
| Name | Vyome Holdings, Inc |
|---|---|
| Ticker | HIND |
| CIK | 0001427570 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Biotechnology |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Marktkapitalisierung | 11,9 Mio. USD |
| Beta | 1,42 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | 319,714 | -10,262,007 | -4.86 | 6,497,177 | |
| 2025-09-30 | 10-Q | 34,627 | -8,433,811 | -3.12 | 7,045,396 | 2,529,713 |
| 2025-06-30 | 10-Q | 1,242,000 | -2,630,000 | -2.25 | 9,028,000 | 5,829,000 |
| 2025-03-31 | 10-Q | 1,113,000 | 1,474,000 | 18.98 | 6,483,000 | 1,230,000 |
| 2024-12-31 | 10-K | 256,944 | -1,447,461 | -###.## | 1,381,561 | -253,000 |
| 2024-09-30 | 10-Q | 84,526 | -547,772 | -###.## | 1,278,297 | 1,487,000 |
| 2024-06-30 | 10-Q | 1,965,000 | -1,595,000 | -91.56 | 6,393,000 | 3,035,000 |
| 2024-03-31 | 10-Q | 1,944,000 | -2,193,000 | -135.37 | 8,231,000 | 4,534,000 |
| 2023-12-31 | 10-K | 8,678,000 | -11,387,000 | -110.87 | 10,663,000 | 6,663,000 |
| 2023-09-30 | 10-Q | 2,155,000 | -3,534,000 | -59.36 | 7,827,000 | 3,083,000 |
| 2023-06-30 | 10-Q | 2,254,000 | -3,493,000 | -1.08 | 11,852,000 | 6,738,000 |
| 2023-03-31 | 10-Q | 2,287,000 | -2,662,000 | -1.56 | 16,352,000 | 7,758,000 |
| 2022-12-31 | 10-K | 11,240,000 | -46,214,000 | -108.90 | 11,142,000 | 3,661,000 |
| 2022-09-30 | 10-K | -12,186,000 | -27.01 | 26,485,000 | 18,953,000 | |
| 2022-09-30 | 10-Q | 2,798,000 | -12,186,000 | -27.01 | 28,456,000 | 18,953,000 |
| 2022-06-30 | 10-Q | 2,892,000 | -9,444,000 | -24.45 | 41,925,000 | 30,776,000 |
| 2022-06-30 | 10-K | -9,444,000 | -24.59 | 40,357,000 | 30,776,000 | |
| 2022-03-31 | 10-K | -8,115,000 | -21.87 | 45,623,000 | 36,959,000 | |
| 2022-03-31 | 10-Q | 2,440,000 | -8,115,000 | -21.87 | 47,270,000 | 36,959,000 |
| 2021-12-31 | 10-K | 13,600,000 | -63,146,000 | -288.97 | 52,531,000 | 44,334,000 |
Fondsaktivität (Vorquartalsvergleich)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
Keine Insider-Käufe/Verkäufe in den letzten 12 Monaten.
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.